Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) in Texas
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Craig, William MD | $0.41 | 9.3K |
| Reyes, Guillermo M.D. | $0.40 | 5.8K |
| Hashmi, Arjumand M.D. | $0.35 | 4.7K |
| Attar, Mohammed M.D | $0.40 | 4.5K |
| Qureshi, Usman MD | $0.39 | 4.0K |
| Zacca, Nadim M.D. | $0.40 | 3.1K |
| Solhpour, Amirreza M.D. | $0.42 | 2.2K |
| Kamat, Suraj MD | $0.41 | 1.7K |
| Alzaghrini, Ghassan M.D | $0.43 | 1.6K |
Texas Pricing in Context
In Texas, CPT code J0153 (Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds)) carries an average Medicare payment of $0.40 — 1% below the national benchmark of $0.40. 43 providers across the state submitted claims for this procedure in 2023, performing 49.5K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $9.26, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Texas lands near $1.17, with self-pay cash prices typically around $2.93. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) cost in Texas?
The average Medicare payment for Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) in Texas is $0.40, which is 1% below the national average of $0.40. Providers in TX typically bill $9.26 for this procedure.
What does Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) cost with insurance in Texas?
With commercial insurance in Texas, Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) costs an estimated $1.17. Without insurance, the estimated cash price is $2.93. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) in Texas?
43 providers in Texas billed Medicare for Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) in 2023, performing 49.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) cheaper in Texas than the national average?
Yes — Injection, Adenosine, 1 Mg (not To Be Used To Report Any Adenosine Phosphate Compounds) costs 1% below the national average in Texas. The state average Medicare payment is $0.40 compared to $0.40 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.